COMMUNIQUÉS West-GlobeNewswire

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
16/09/2026
New data presented in Vienna highlights long-term repeat-dose modeling, mechanistic GI barrier profiling, and deconvolution of payload- and linker-dependent toxicities for complex modalities SAN DIEGO, Sept. 16, 2026 ( [...]
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
16/09/2026
Milestone follows FDA clearance of MAIA’s amended investigational new drug (IND) submission highlighting improved manufacturing capabilities and efficiencies U.S. expansion is funded by a $2.3 million NIH grant to MAIA [...]
Notice of Annual General Meeting 2026
16/09/2026
Notice of Annual General Meeting 2026 ANNOUNCEMENT NO. 314 16 September 2026 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 8 October 2026 at 5.30 p [...]
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
16/09/2026
Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workers VANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Optimi [...]
Cuprina Holdings (Cayman) Limited Announces Pricing of $4.97 million Public Offering
16/09/2026
SINGAPORE, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”), a biomedical company developing and marketing products for the chronic wounds, [...]
DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million
16/09/2026
ATLANTA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today [...]
A.D.A.M. Innovations Expands GeneAI Forecast With New Chronic Disease Risk Assessment Models and Connected Biomarker Integration
16/09/2026
New models for asthma, atopic dermatitis and chronic obstructive pulmonary disease (COPD) expand GeneAI Forecast to 18 conditions, alongside resting heart rate integration from health apps and wearable devices. TOKYO, [...]
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
16/09/2026
Sessions will highlight Orchestra BioMed's collaboration with Medtronic and explore the potential for AVIM Therapy to treat hypertensive heart disease in pacemaker-indicated patients and beyond NEW HOPE, Pa., Sept. 16, [...]
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
16/09/2026
Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies THE WOODLANDS, TX [...]
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum
16/09/2026
Presentation Highlights Clinical Translation of ONP-002 Intranasal Delivery Platform for Concussion Treatment James P. Kelly, MD, Chief Medical Officer of Oragenics, is scheduled to present in the Successful Case [...]
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
16/09/2026
New Preclinical PDAC Data for PRP Show >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Highlights How Reversing Epithelial-Mesenchymal Transition May Deepen & Extend Responses to RAS(ON [...]
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
16/09/2026
LA JOLLA, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that [...]
Major shareholder announcement - BlackRock, Inc.
16/09/2026
16 September 2026 ANNOUNCEMENT NO. 315 Major shareholder announcement - BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that [...]
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
16/09/2026
DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) executives put even more personal capital behind the company, following positive Phase 2a results for its [...]
Gautham Chidambaram Announces New QP & Half-Pound THCA Flower Sizing at Passion Farms
16/09/2026
Passion Farms just made it easier for wholesale buyers to try new strains-rolling out QP and half-pound THCA flower sizes across TX, CA & OK, no more pound minimums. HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- [...]
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
16/09/2026
Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategy ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: [...]
NeuroSigma Expands Payment Options for the Monarch eTNS® System
16/09/2026
Families prescribed Monarch can now pay with digital wallets or third-party installment plans at checkout LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced expanded payment options for [...]
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
16/09/2026
Total national coverage footprint for PENFS increases to over 120 million covered lives CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
16/09/2026
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. [...]

Pages